Clinical Trial Update: Discontinuation of Postmenopausal Hormone Therapy: Impact on the Cardiovascular System and Quality of Life [Phase 4]

View source ↗

Summary

Phase 4 trial update on discontinuation of postmenopausal hormone therapy and its effects on cardiovascular outcomes and quality of life.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Cardiovascular Diseases
• Menopause

Drugs mentioned

• Postmenopausal hormone therapy (estrogen-based therapy)

Snippet

Sponsor: Hanna Savolainen-Peltonen | Conditions: Menopause, Atherosclerosis | Phase 4 | Status: UNKNOWN